Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF) added three names to its portfolio today as it scaled back several positions. The ETF had shared its top holdings in the C$104mm fund as of 6/9 on its website:

The complete portfolio also included six other names and cash of 0.24%.

The ETF manager added rour new names today:

ABcann Global (TSXV: ABCN) (OTC: ABCCF) and Maricann Group (CSE: MARI) (OTC: MRRCF) are both newly trading LPs, while Invictus MD Strategies (TSXV: IMH) (OTC: IVITF) has been trading for a couple of years but became an LP only recently following its acquisition of Acreage Farms. Arena Pharmaceuticals (NASDAQ: ARNA) is a biotech that seems to be an odd choice, as it isn’t developing any drugs using cannabinoids but rather one that targets the CB2 receptor. To make room for the new additions, Horizons reduced Insys (NASDAQ: INSY) and Zynerba (NASDAQ: ZYNE).

Horizons has added names to its portfolio before they have been included in the Soloactive index, though this is not the first time. Since its debut two months ago, it has also added 22nd Century Group and Hydropothecary. Soloactive will be rebalancing its North American Medical Marijuana Index later this month.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email